These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8197103)

  • 21. Craniopharyngioma recurrence and growth hormone therapy.
    Clayton PE; Price DA; Shalet SM; Gattemaneni HR
    Lancet; 1988 Mar; 1(8586):642. PubMed ID: 2894566
    [No Abstract]   [Full Text] [Related]  

  • 22. Craniopharyngioma.
    Boop FA
    J Neurosurg; 2007 Jan; 106(1 Suppl):1-2; discussion 2. PubMed ID: 17233304
    [No Abstract]   [Full Text] [Related]  

  • 23. Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma.
    Schoenle EJ; Zapf J; Prader A; Torresani T; Werder EA; Zachmann M
    J Clin Endocrinol Metab; 1995 Feb; 80(2):374-8. PubMed ID: 7852493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Craniopharyngioma.
    Till K
    Childs Brain; 1982; 9(3-4):179-87. PubMed ID: 7049599
    [No Abstract]   [Full Text] [Related]  

  • 25. Craniopharyngioma in Finland. A study of 123 cases.
    Sorva R; Heiskanen O
    Acta Neurochir (Wien); 1986; 81(3-4):85-9. PubMed ID: 3489356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the radicalness of the removal of craniopharyngioma of the 3d ventricle in children and the possible sources of their continued growth and recurrence].
    Konovalov AN; Vikhert TM; Korshunov AG; Gorelyshev SK
    Zh Vopr Neirokhir Im N N Burdenko; 1988; (6):7-12. PubMed ID: 3239313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Surgery for craniopharyngioma].
    Ashkenazi E; Constantini S; Shoshan Y; Umansky F; Shalit M
    Harefuah; 1990 Dec; 119(11):359-61. PubMed ID: 2289710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pulsatile gonadotropin-releasing hormone substitution following excision of a craniopharyngioma with suprasellar invasion].
    Koloszár S; Bártfai G; Sas M
    Orv Hetil; 1991 Jan; 132(3):139-41. PubMed ID: 1996204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience of external beam radiotherapy given adjuvantly or at relapse following surgery for craniopharyngioma.
    Pemberton LS; Dougal M; Magee B; Gattamaneni HR
    Radiother Oncol; 2005 Oct; 77(1):99-104. PubMed ID: 16216361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic shunting of residual intraparenchymatous cystic craniopharyngioma.
    Economos D
    Acta Neurochir Suppl (Wien); 1979; 28(2):363-6. PubMed ID: 290207
    [No Abstract]   [Full Text] [Related]  

  • 31. Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement.
    Niu DM; Guo WY; Pan HC; Wong TT
    Childs Nerv Syst; 2002 Apr; 18(3-4):164-5. PubMed ID: 11981627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed neurotoxic complication of intracavitary bleomycin therapy for craniopharyngioma in a child who had previously undergone radiosurgery. Case report.
    Belen D; Er U; Yigitkanli K; Bolay H
    J Neurosurg; 2007 May; 106(5 Suppl):391-3. PubMed ID: 17566208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pancreatitis induced by steroids. Apropos of a case and review of the literature].
    Alvarez-Cienfuegos Suárez J; Ardaiz San Martin J; Colas Vicente A; Jorge Cheverri J; Inchausti Teja JL
    Rev Clin Esp; 1980 Jul 15-31; 158(1-2):81-2. PubMed ID: 7422978
    [No Abstract]   [Full Text] [Related]  

  • 34. Craniopharyngiomas in children. Long-term effects of conservative surgical procedures combined with radiation therapy.
    Fischer EG; Welch K; Shillito J; Winston KR; Tarbell NJ
    J Neurosurg; 1990 Oct; 73(4):534-40. PubMed ID: 2398383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does the choice of surgical approach to insert an intratumoral catheter influence the results of intratumoral cystic treatment?
    Zanon N; Cavalheiro S; da Silva MC
    Surg Neurol; 2008 Jul; 70(1):66-9; discussion 69. PubMed ID: 18207525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of radiation treatment in craniopharyngioma.
    Chin HW; Maruyama Y; Young B
    Strahlentherapie; 1983 Dec; 159(12):741-4. PubMed ID: 6665811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience.
    Kalina MA; Wilczek M; Kalina-Faska B; Skała-Zamorowska E; Mandera M; Małecka Tendera E
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):45-51. PubMed ID: 25536662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gamma Knife surgery for craniopharyngioma: report on a 20-year experience.
    Lee CC; Yang HC; Chen CJ; Hung YC; Wu HM; Shiau CY; Guo WY; Pan DH; Chung WY; Liu KD
    J Neurosurg; 2014 Dec; 121 Suppl():167-78. PubMed ID: 25434950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma.
    Müller HL; Gebhardt U; Pohl F; Flentje M; Emser A; Warmuth-Metz M; Kolb R; Calaminus G; Sörensen N
    Klin Padiatr; 2006; 218(6):315-20. PubMed ID: 17080333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Craniopharyngioma.
    Wisoff JH
    J Neurosurg Pediatr; 2008 Feb; 1(2):124-5; discussion 125. PubMed ID: 18352780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.